Cancer (Oncology)
Cancer (Oncology)
Alecensa 150® Alectinib Capsules
Alectinib Hydrocloride 150mg
- Composition
- Alectinib Hydrocloride 150mg
- Dosage form
- Capsules
- Pack size
- Strip of 8 Capsule
- Manufacturer
- Roche
- Also known as
- Alecensa
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Alecensa 150 mg contains alectinib, a targeted anticancer medicine used to treat ALK-positive non-small cell lung cancer. It is used in eligible adults following complete surgical removal of certain tumours to reduce recurrence risk, and for advanced or metastatic ALK-positive NSCLC.
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Licensed wholesalerForm 20B & 21B, Delhi
Discreet packagingPlain outer box, no product labels
Worldwide shippingDirect to you or your customer